Brazils Health Ministry approves China Sinovac shot for some children

Brazil's Health Ministry on Friday approved use of Sinovac Biotech Ltd's (SVA.O) COVID-19 vaccine, Coronavac, for children ages 6 to 17. In a news conference announcing the addition of Coronavac to the national vaccination plan, Deputy Health Minister Rodrigo Cruz said the ministry has 6 million doses of the vaccine available, with states and cities having their own stocks. The Chinese vaccine was tested in Brazil at Sao Paulo's Butantan Institute, a leading biomedical center tied to the state government. Coronavac received authorization for emergency use in adults in January last year and was the first vaccine to be used in Brazil. Later, however, it was supplanted by other shots and is no longer being used in adults. Brazil has already authorized the Pfizer (PFE.N)/BioNTech vaccine for children between 5 and 11 years old.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!